Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.
Mr. Kevin Smith is the President of Inogen Inc, joining the firm since 2023.
What is the price performance of INGN stock?
The current price of INGN is $6.31, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Inogen Inc?
Inogen Inc belongs to Health Care industry and the sector is Health Care
What is Inogen Inc market cap?
Inogen Inc's current market cap is $171.8M
Is Inogen Inc a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Inogen Inc, including 2 strong buy, 5 buy, 1 hold, 0 sell, and 2 strong sell